A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study designed to
demonstrate the safety and efficacy of MILR1444A compared with placebo in reducing the airway
reaction to an inhaled aeroallergen solution in adult patients with mild allergic asthma. The
study will randomize approximately 24 patients at five study centers. In the event of patient
discontinuation from the study, additional patients may be enrolled at the discretion of the
Sponsor.